CRISPR Therapeutics AG ($CRSP)
Filing Information
| Accession Number | 0001193125-26-022845 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 26, 2026 |
| Document Date | Jan 22, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
104,916
Total Value
$3,683,950.48
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Shares | โ | Jan 22, 2026 | Exercise/Conversion | 34,972 | $45.15 | $1,578,985.80 | 41,739 | Direct | โ | View Details | |
Chief Financial Officer | Common Shares | โ | Jan 22, 2026 | Sale | 34,972 | $60.19 | $2,104,964.68 | 6,767 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jan 22, 2026 | Exercise/Conversion | 34,972 | $0.00 | $0.00 | 41,667 | Direct | โ | View Details |